Investigation of sanguinarine and chelerythrine effects on LPS-induced inflammatory gene expression in THP-1 cell line
Language English Country Germany Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
22592163
DOI
10.1016/j.phymed.2012.04.001
PII: S0944-7113(12)00123-7
Knihovny.cz E-resources
- MeSH
- Anti-Inflammatory Agents pharmacology therapeutic use MeSH
- Benzophenanthridines pharmacology therapeutic use MeSH
- Cell Line MeSH
- Chemokine CCL2 genetics metabolism MeSH
- Gene Expression drug effects MeSH
- Phytotherapy MeSH
- Transcription, Genetic drug effects MeSH
- Interleukin-6 genetics metabolism MeSH
- Isoquinolines pharmacology therapeutic use MeSH
- Humans MeSH
- Lipopolysaccharides MeSH
- Macrophages drug effects metabolism MeSH
- Inflammation Mediators metabolism MeSH
- Prednisone pharmacology therapeutic use MeSH
- Plant Extracts pharmacology therapeutic use MeSH
- Inflammation drug therapy genetics metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Anti-Inflammatory Agents MeSH
- Benzophenanthridines MeSH
- CCL2 protein, human MeSH Browser
- chelerythrine MeSH Browser
- Chemokine CCL2 MeSH
- Interleukin-6 MeSH
- Isoquinolines MeSH
- Lipopolysaccharides MeSH
- Inflammation Mediators MeSH
- Prednisone MeSH
- Plant Extracts MeSH
- sanguinarine MeSH Browser
Quaternary benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine have been used in folk medicine for their wide range of useful properties. One of their major effect is also anti-inflammatory activity, that is not clarified in detail. This study focused on the ability of these alkaloids to modulate the gene expression of pro-inflammatory tumour necrosis factor α (TNF-α), monocyte chemoattractant protein 1 (MCP-1, also known as CCL-2), interleukin (IL)-6, IL-1β and anti-inflammatory cytokines IL-1 receptor antagonist (IL-1RA) and IL-10. The effect of these alkaloids was compared with that of conventional drug prednisone. Human monocyte-derived macrophages were pre-treated with alkaloids or prednisone and inflammatory reaction was induced by lipopolysaccharide. Changes of gene expression at the transcriptional level of mentioned cytokines were measured. In our study mainly affected pro-inflammatory cytokines were CCL-2 and IL-6. Two hours after LPS stimulation, cells influenced by sanguinarine and chelerythrine significantly declined the CCL-2 expression by a factors of 3.5 (p<0.001) and 1.9 (p<0.01); for those treated with prednisone the factor was 5.3 (p<0.001). Eight hours after LPS induction, both alkaloids significantly diminished the CCL-2 expression. The lower expression was found for sanguinarine--lower by a factor of 4.3 than for cells treated with the vehicle (p<0.001). Two hours after LPS stimulation, cells treated with sanguinarine decreased the IL-6 mRNA level by a factor of 3.9 (p<0.001) compared with cells treated with the vehicle. Chelerythrine decreased the level of IL-6 mRNA by a factor of 1.6 (p<0.001). Sanguinarine decreased gene expression of CCL-2 and IL-6 more than chelerythrine and its effect was quite similar to prednisone. Four hours after LPS stimulation, cells pre-treated with sanguinarine exhibited significantly higher expression (a factor of 1.7, p<0.001) of IL-1RA than cells without sanguinarine treatment. Our results help to clarify possible mechanisms of action of these alkaloids in the course of inflammation.
References provided by Crossref.org
Cellular responses induced by Cu(II) quinolinonato complexes in human tumor and hepatic cells